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Abstract:
Background and Objectives: Poly-substance use and psychiatric comorbidity are common among
individuals receiving substance detoxification services. Posttraumatic stress disorder (PTSD) and
major depressive disorder (MDD) are the most common co-occurring psychiatric disorders with
substance use disorder (SUD). Current treatment favors a one-size-fits-all approach to treating
addiction focusing on one substance or one comorbidity. Research examining patterns of
substance use and comorbidities can inform efforts to effectively identify and differentially treat
individuals with co-occurring conditions.
Methods: Using latent class analysis, the current study identified four patterns of PTSD, MDD,
and substance use among 375 addiction treatment seekers receiving medically supervised
detoxification.
Results: The four identified classes were: 1) a PTSD-MDD-Poly SUD class characterized by
PTSD and MDD occurring in the context of opioid, cannabis, and tobacco use disorders; 2) an
MDD-Poly SUD class characterized by MDD and alcohol, opioid, tobacco, and cannabis use
disorders; 3) an alcohol-tobacco class characterized by alcohol and tobacco use disorders; and 4)
an opioid-tobacco use disorder class characterized by opioid and tobacco use disorders. The
observed classes differed on gender and clinical characteristics including addiction severity,
trauma history, and PTSD/MDD symptom severity.
Discussion and Conclusions: The observed classes likely require differing treatment approaches.
For example, people in the PTSD-MDD-Poly SUD class would likely benefit from treatment
approaches targeting anxiety sensitivity and distress tolerance, while the opioid-tobacco class
would benefit from treatments that incorporate motivational interviewing. Appropriate matching
of treatment to class could optimize treatment outcomes for polysubstance and comorbid
psychiatric treatment seekers. These findings also underscore the importance of well-developed
referral networks to optimize outpatient psychotherapy for detoxification treatment-seekers to
enhance long-term recovery, particularly those that include transdiagnostic treatment
components.
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Patterns of Co-Occurring Addictions, PTSD, and MDD in Detoxification Treatment Seekers:
Implications for Improving Detoxification Treatment Outcomes
1. Introduction
Psychiatric comorbidity is highly prevalent in addiction treatment seekers; for instance,
11-41% of people seeking treatment for a substance use disorder (SUD) also meet criteria for
posttraumatic stress disorder (PTSD: Read, Brown, & Kahler, 2004). SUD-PTSD comorbidity is
especially noteworthy as this comorbidity is associated with more intense cravings and higher
rates of relapse following addiction treatment (Berenz & Coffey, 2012) than is SUD alone. Both
PTSD and SUD are associated with increased risk for major depressive disorder (MDD: Lai,
Cleary, Sitharthan, & Hunt, 2015). Further, PTSD or SUD comorbid with MDD is associated
with more severe psychosocial impairment than either PTSD or SUD alone (Erfan, Hashim,
Shaheen, & Sabry, 2010). Difficulties in treating SUD comorbidities may be exacerbated in the
detoxification setting where treatment seekers may have different motivations and priorities than
those in traditional outpatient settings (Freyer-Adam, Gaertner, Rumpf, John, & Hapke, 2010).
Indeed, the few differential predictors of SUD treatment outcome identified in Project MATCH
are characteristics that are more common in PTSD-SUD samples: more severe psychopathology
and anger (Coffey, Schumacher, Brimo, & Brady, 2005). The goal of this study was to identify
comorbidity profiles in a special population of people who use substances, detoxification
treatment seekers, in order to inform integrative SUD-comorbidity treatment protocols.
Given the prevalence and negative sequelae of psychiatric comorbidity in addiction
treatment seekers, current practice guidelines recommend integrative treatments that address
both addiction problems and co-occurring psychiatric problems throughout the course of
treatment (SAMHSA, 2006). Integrated protocols often consist of cognitive behavioral therapy
(CBT) combined with motivational interviewing techniques or a combination of different CBT
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protocols. Although integrative treatments are the most efficacious option, many patients still do
not respond to these treatments, leaving room for improvement and innovation (Hien et al.,
2009). Currently, there is no established standard regarding what components, treatment targets,
or number of sessions to include in integrative treatment protocols. Often providers are left to
make educated guesses about these important decisions. Research targeted towards better
understanding subgroups of detoxification seekers is important to highlight potential differences
that can be targeted in treatment. Yet, detoxification seekers have often been excluded from large
scale psychotherapy outcome research making it unclear how results from prior patient
characteristic/treatment matching research apply to this group (Project MATCH, 1997).
One area of clarity in treatment guidelines is the necessity of delivering treatment for an
appropriate duration – a challenge in the detoxification setting given that treatment goals in this
context are focused on medically stabilizing patients from extreme use (SAMHSA, 2006).
Despite this challenge, detoxification facilities, as the entry point into addiction treatment, are
also in a unique position to increase patient success. Detoxification facilities can make long-term
treatment recommendations following stabilization that are individualized to the unique needs
and problem areas experienced by patients. People seeking treatment at detoxification centers
may be more motivated for treatment (Freyer-Adam et al., 2010); yet, people with comorbidities
are more likely to drop out of treatment than people without comorbidities, emphasizing the need
to match comorbidity profiles to post-detox referral patterns (Tómasson & Vaglum, 1998).
In addition to psychiatric comorbidities, polysubstance use also creates challenges for
treatment. Polysubstance use is associated with more severe addiction problems (Moss,
Goldstein, Chen, & Yi, 2015), more frequent emergency department admissions (Tait, Hulse,
Robertson, & Sprivulis, 2005), greater risk of both non-fatal and fatal overdose (Darke et al.,

RUNNING HEAD: Patterns of Comorbidity in Detoxification Treatment Seekers

5
2014), greater dropout in detox settings (Tómasson & Vaglum, 1998), and greater risk for
relapse following treatment than outcomes for people who use a single substance (Branson,
Clemmey, Harrell, Subramaniam, & Fishman, 2012). Furthermore, polysubstance use is
associated with increased rates of both MDD and PTSD than rates of these disorders among
people who use a single substance (Conway et al., 2013); this is particularly true among those
who have experienced interpersonal violence (Ullman & Long, 2008).
Many forms of interpersonal violence disproportionately affect more women than men
(Black et al., 2011); which likely contributes to gender-related PTSD-SUD disparities. Women
often present with more complex psychiatric symptoms and severe symptoms than men, related
to higher rates of interpersonal violence including rape (Najavits, Weiss, & Shaw, 1997).
Although women are more likely to have PTSD, men are more likely to seek treatment for SUDs
(Najavits, Weiss, & Shaw, 1997; Cohen, Feinn, Arias, Kranzler, 2007). These findings
underscore the importance of examining gender differences in studies of psychiatric and SUD
comorbidity.
Latent class analysis (LCA) is a person-centered statistical technique that identifies
subgroups of individuals who share common values on some set of variables. This feature makes
it an ideal tool for examining patterns of polysubstance use and psychiatric comorbidity in
people who use substances. Furthermore, in the context of detoxification treatment, it can inform
the referral process used to determine appropriate treatment options following medical
stabilization by identifying subgroups of patients with common problem areas. Research using
LCA in SUD populations has typically identified three classes: a limited involvement class
(characterized by alcohol, tobacco, and marijuana use); a moderate involvement class
(characterized by substance use including alcohol, tobacco, marijuana, and amphetamine use);
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and an extended involvement class (characterized by the use of a large number of substances
including alcohol, tobacco, marijuana, amphetamines, non-medical prescription drugs, and other
illicit drugs). Members of the extended involvement class tend to have elevated levels of anxiety
and depression (Connor et al., 2013). Yet, most research conducting LCAs in people who use
substances has not examined PTSD as a comorbid diagnosis. Further, when studies have
examined PTSD it was as a covariate, rather than as an indicator variable (a variable used to
define classes). This conceptual difference can dramatically impact findings – considering PTSD
as an indicator suggests that PTSD is considered to have a possible shared etiology while
considering it as a covariate suggests that PTSD is considered more a post-hoc complication.
Utilizing PTSD as a covariate is contrary to the tension-reduction model of PTSD-SUD
comorbidity which postulates that SUD problems develop after a traumatic event as part of a
maladaptive coping process (Berenz & Coffey, 2012).
Despite the growing literature applying LCA to polysubstance use and comorbid
psychiatric disorders, limited research has attempted to identify subgroups of people in
detoxification treatment-seekers. As described, this is a substantial limitation given that class
identification in this unique population can inform treatment and referral approaches which may
be especially important in a short-term setting.
1.1 Current Study
The current study used LCA to examine how PTSD, multiple SUDs, and MDD may cooccur in a sample of adults seeking medically supervised detoxification. We specifically chose to
focus on MDD as an additional comorbidity given the frequency of MDD diagnoses in relation
to both PTSD and SUDs and is (Quello, Brady, Sonne, 2005; Dixon, Resick, & Nishith, 2005).
We also sought to examine differences between LCA-identified subgroups on key clinical
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characteristics relevant to PTSD, polysubstance use, or MDD including addiction problem
severity, trauma history (i.e., sexual/physical assault in childhood vs. adulthood), and
PTSD/MDD symptom severity. Finally, given established gender differences in the prevalence
of psychiatric disorders, we also considered how the observed subgroups differed according to
gender.
Hypotheses:
1.

We hypothesized that multiple classes would be identified reflecting the complexity of
psychiatric comorbidity and polysubstance use.

2.

We further hypothesized that classes with greater psychiatric comorbidity (i.e., greater
proportion of probable PTSD diagnoses) would experience more severe addiction
problems, greater trauma history, higher psychiatric symptom severity, and contain a
larger proportion of women than other classes.

2. Materials and Method
2.1 Participants
Participants were 375 adults seeking medically assisted detoxification at the inpatient unit
of the Alcohol, Drug Addiction, and Mental Health Crisis Center in Northeast Ohio. This
detoxification center is a private, non-profit organization providing both residential (i.e.,
inpatient medically assisted detoxification, housing for intoxicated individuals, etc.) and nonresidential (i.e., alcohol/drug addiction assessments and treatment referrals, group counseling,
12-step meetings, etc.) services regardless of patients’ ability to pay. Participants were recruited
within two days of their admission (M = 2.02, SD = 1.35) and, on average, participants spent 4.5
days receiving treatment at the detoxification facility. Consistent with the detoxification center’s
demographics (91% Caucasian, 65% male) participants largely identified as Caucasian (93.2%)

RUNNING HEAD: Patterns of Comorbidity in Detoxification Treatment Seekers

8
with 6.9% identifying as African-American, 0.5% Asian, and 6.9% identifying their ethnicity as
Hispanic/Latino. The majority of participants were men (61.3%). The average age was 35.6
years (SD = 11.4) and the average education level was 12.2 years (SD = 1.9).
2.2 Procedure
Participants were approached and consented by research staff. Consenting participants
completed a questionnaire battery. Demographic and SUD diagnosis data were collected by
medical chart review. After survey completion, participants were provided with a choice of
either a $5.00 gift card or a candy bar to compensate them for their time. Data were collected
between February 2013 and April 2014.
2.3 Materials
2.3.1 Trauma history. Trauma history and Criterion A for the DSM-IV-TR definition of
PTSD were assessed using the 21 traumatic event items from the Life Stressor Checklist-Revised
(LSC-R: Wolfe, Kimerling, Brown, Chrestman, & Levin, 1996).
2.3.2 PTSD. The PTSD Checklist-Civilian (PCL-C: Blanchard, Jones-Alexander,
Buckley, & Forneris, 1996) was used to assess PTSD symptoms. The PCL-C is a 17-item
measure that asks participants to rate how frequently they have experienced each of the 17 PTSD
symptoms corresponding to DSM-IV-TR criteria. Participants were asked to rate how often or
how much they had been bothered by each symptom in the past month on a scale ranging from 1
(‘Not at all/never’) to 5 (‘Extremely/daily or almost daily’). In the present study, Cronbach’s
alpha for the PCL-C was 0.96. Items from the well-validated Posttraumatic Diagnostic Scale
(PDS: Foa, Cashman, Jaycox, & Perry, 1997) were included to assess impairment and duration
of symptoms; responses to the PCL-C, LSC-R (for items related to criterion A) and PDS were
combined to determine probable PTSD diagnostic status. Specifically, participants were
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classified as having a probable PTSD diagnosis if they (a) reported experiencing at least one
traumatic event meeting Criterion A as assessed by the LSC-R; (b) endorsed at least 1 reexperiencing symptom, 3 avoidance symptoms, and 2 hyperarousal symptoms (symptom
endorsement was defined as a rating of 3 or higher) on the PCL-C (NCPTSD, 2014); (c) reported
experiencing these symptoms for at least 1 month; and (d) reported functional impairment in at
least 1 domain (e.g., home, work, school, etc.) from endorsed symptoms on by the PDS.
2.3.3 Depression. The Center for Epidemiologic Studies Depression Scale-Revised
(CESD-R: Eaton, Smith, Ybarra, Muntaner, & Tien, 2004) was used to assess depression. In the
present study, participants were asked to rate how often they had experienced each symptom in
the past month (rather than the past week) on a scale ranging from 0 (‘Not at all or less than one
day’) to 4 (‘Nearly every day for the past month’). In the present study, Cronbach’s alpha was
0.94. Participants’ responses were used to determine both probable diagnostic levels of
depression using the algorithmic classification scheme reported by Eaton et al. as well as to
assess depression symptom severity.
2.3.4 SUDs. Licensed staff clinicians assessed SUDs at intake using the DSM Checklist
for SUDs, a semi-structured interview that has demonstrated good reliability and validity
(Hudziak et al., 1993). Substance use disorder diagnostic status for each of the following
substances (opiates, alcohol, sedatives, amphetamines, cocaine, tobacco, and cannabis) was
determined via chart review.
2.3.5 Problematic substance use. Problematic substance use was assessed using the
Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST: Ali et al., 2002). The
ASSIST is a 6-item screening test that assesses difficulties arising from an individual’s use of
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different psychoactive substances; the six items are assessed for each type of substance endorsed.
Cronbach’s alpha for each substance subscale ranged from .62 (tobacco) - .95 (opioid).
2.3.6 Substance use consequences. Negative consequences related to substance use were
assessed using the Shortened Inventory of Problems-Alcohol and Drugs (SIP-AD: Blanchard,
Morgenstern, Morgan, Lobouvie, & Bux, 2003). The SIP-AD is a 15-item questionnaire that asks
participants to rate how frequently they have experienced different negative consequences
resulting from their alcohol or drug use. Items reflect a broad range of domains in which
psychosocial impairment may be experienced including psychosocial relationships, financial
responsibilities, physical health, etc. Each item is rated on a scale ranging from 0 (‘Never’) to 3
(‘Daily or almost daily’). In the present study, Cronbach’s alpha was 0.93.
2.4 Statistical analyses
Latent class analysis (LCA) was used to characterize the patterns of co-occurring SUDs,
PTSD, and MDD in the sample. LCA identifies latent classes or groups of participants based on
a given set of indicator variables that are hypothesized to represent one or more latent variables.
This analysis used nine indicator variables to determine class composition. Seven of these
indicators were dichotomous SUD diagnoses (yes/no) as determined by chart review. Two
additional indicator variables were probable PTSD and MDD diagnosis coded dichotomously
using the algorithms described above.
The LCA was conducted in an exploratory fashion using Mplus (Version 5.0). Multiple
models were examined starting with a two class model and adding additional classes. Model fit
was evaluated using a variety of statistical criteria including the Bayesian Information Criterion
(BIC), sample size adjusted BIC (SSA-BIC), and Akaike Information Criterion (AIC) where
smaller values indicate better fit. The model was also evaluated with the Lo-Mendell-Rubin test
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(LMRT) and the bootstrap likelihood ratio test (BLRT) which indicate whether a model with k
classes better fits the data than a model with k-1 classes. In other words, if the p-value is greater
than 0.05 the model with k classes is not significantly different from the k-1 class and the more
parsimonious model is preferred. Finally, model fit was also assessed via the entropy value,
where values closer to 1.0 indicate better classification.
Class proportions and conditional item probabilities for each indicator variable by class
were then examined to determine the characteristics of observed classes. If 60% or more of the
participants in a class had the characteristic, then the characteristic was said to be a
distinguishing feature of the class (Galatzer‐Levy, Nickerson, Litz, & Marmar, 2013).
Following the LCA, non-indicator variables, or external variables, were considered to
evaluate the practical relevance and clinical significance of the best fitting solution. Pearson chisquare analyses were used for dichotomous and categorical non-indicator variables while
Tukey’s HSD/ Dunnett’s T3 post-hoc tests were used following statistically significant one-way
ANOVAs for continuous non-indicator variables.
3. Results
3.1 Descriptive statistics
Trauma history was prevalent in the sample, with 91.8% meeting criteria for at least 1
Criterion A event. On average, participants reported experiencing 4.6 (SD = 3.8) types of
Criterion A events with the most commonly endorsed events consisting of witnessing a serious
accident (48.1%), being in a serious accident (47.4%), and witnessing violence between family
members before the age of 16 (38.2%).
Prevalence rates for each diagnosis are listed in the right-hand column of Table 1. The
average number of SUD diagnoses was 3.26 (SD = 1.32) with the most common diagnoses being
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opioid use disorder (76.0%), alcohol use disorder (56.0%), and tobacco use disorder (81.6%).
Nearly half of the sample (47.2%) met criteria for probable PTSD, and 64.0% met criteria for
probable MDD.
3.2 Latent class findings
Table 2 presents the fit indices for each model tested. While the LMR LRT and the
entropy values supported a 2-class model and the BIC supported a 3-class model, the AIC, SSABIC, and the BLRT all supported a 4-class model. Given that the greatest support existed for the
4-class solution, this model was selected for further examination. Class proportions are displayed
in Table 1. The number of participants in each class was evenly distributed; class 1 consisted of
23.7% of the sample, class 2 made up 25.1% of the sample, class 3 consisted of 22.7% of the
sample, and class 4 made up 28.5% of the sample.
Class one was characterized as the PTSD-MDD-Poly SUD class. In this class, nearly
85% of participants met criteria for probable PTSD and all met criteria for probable MDD.
Regarding SUDs, 100% met criteria for opioid use disorder, nearly 90% of participants met
criteria for tobacco use disorder, and approximately 65% met criteria for cannabis use disorder.
Class two was characterized as the MDD-Poly SUD class. In this class, nearly 80% qualified for
probable MDD, 100% qualified for alcohol use disorder, over 90% qualified for opioid use
disorder, and approximately 80% met tobacco use disorder and cannabis use disorder criteria.
Class three was characterized as the alcohol-tobacco SUD class. In this class, 100% had an
alcohol use disorder, and nearly 75% had a tobacco use disorder. Finally, class four was
characterized as the opioid-tobacco SUD class. In this class, nearly 100% had an opioid use
disorder, and 84% had a tobacco use disorder.
3.3 Class Differences
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Means, standard deviations, and class differences on external variables are reported by
class in Table 3. Analyses of class differences focused on differences between the PTSD-MDDPoly SUD class compared to the other classes given our hypothesis that subgroups displaying the
greatest psychiatric comorbidity would report more severe addiction problems, more extensive
psychiatric symptom severity, and would contain a greater proportion of women.
Overall, those in the PTSD-MDD-Poly SUD class reported greater negative
consequences resulting from their substance use compared to all other classes observed (MDDPoly SUD: MDiff = 3.82, SE = 1.16, p = 0.007; alcohol-tobacco SUD: MDiff = 7.90, SE = 1.35, p <
0.001; opioid-tobacco SUD: MDiff = 7.63, SE = 1.22, p < 0.001). In addition, they reported more
severe opioid problems than all of the other classes, more severe cannabis, sedative, and cocaine
problems than the alcohol-tobacco, and the opioid-tobacco SUD classes and more severe
amphetamine problems than the alcohol-tobacco SUD class. However, they reported fewer
alcohol problems than either the MDD-Poly SUD or the alcohol-tobacco SUD classes.
In terms of trauma history, a greater proportion of the PTSD-MDD-Poly SUD class
reported experiencing physical assault both before and after age 16 relative to the opioid-tobacco
SUD class (physical assault <16: χ2[1] = 5.32, p = 0.02; physical assault > 16: χ2[1] = 9.36, p =
0.02); while a greater proportion of participants in PTSD-MDD-Poly SUD class reported
experiencing sexual assault both before and after age 16 compared to the alcohol-tobacco (sexual
assault < 16: χ2[1] = 5.49, p = 0.02; sexual assault > 16: χ2[1] = 7.80, p = 0.005) and opioidtobacco classes (sexual assault < 16: χ2[1] = 13.83, p < 0.001; sexual assault > 16: χ2[1] = 13.25,
p < 0.001).
The PTSD-MDD-Poly SUD class also reported greater PTSD symptom severity
compared to all of the other classes (MDD-Poly SUD: MDiff = 9.31, SE = 2.43, p = 0.001;
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alcohol-tobacco SUD: MDiff = 17.27, SE = 2.59, p < 0.001; opioid-tobacco SUD: MDiff = 23.63,
SE = 2.01, p < 0.001) and more severe MDD symptom severity relative to the alcohol-tobacco
(MDiff = 19.67, SE = 2.51, p < 0.001) and the opioid-tobacco classes (MDiff = 19.00, SE = 2.11, p
< 0.001).
Finally, a greater proportion of the PTSD-MDD-Poly SUD class was comprised of
females compared to all of the other classes (MDD-Poly SUD: χ2[1] = 10.97, p = 0.001; alcoholtobacco SUD: χ2[1] = 18.66, p < 0.001; opioid-tobacco SUD: χ2[1] = 9.57, p= 0.002).
4. Discussion
The present results underscore the extent to which psychiatric comorbidity is prevalent
among detoxification treatment-seekers; 47.2% of the sample met criteria for probable PTSD,
and rates of probable PTSD were over 50% in half of the classes identified. Regarding probable
MDD, 64% of the sample met criteria, and the rate of probable MDD ranged in the classes from
40-79%. One difficulty in providing integrative treatment for PTSD-SUD comorbidity is
adequately targeting polysubstance use and comorbid psychiatric disorders. This study used LCA
to characterize the comorbidity patterns of probable PTSD, MDD, and SUDs and the clinical
characteristics associated with those patterns in a sample of medical detoxification treatmentseekers. The challenge of addressing multiple substances and comorbidities is heightened in the
detoxification center treatment environment given the emphasis on short-term stabilization to
facilitate the longer-term goal of recovery from addiction.
We identified four different and relatively equal sized classes: the PTSD-MDD-Poly
SUD group, the MDD-Poly SUD group, the alcohol-tobacco SUD group, and the opioid-tobacco
SUD group. The classes not characterized by polysubstance use were primarily differentiated by
the presence of alcohol vs. opioid use disorders. Given that a 3-class solution has typically been
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found to best describe the patterns of polysubstance use and comorbid psychiatric disorders, it is
notable that we found evidence for a 4-class solution (Connor et al., 2013; Tomczyk et al., 2015;
Galatzer-Levy et al., 2013). This is likely due to our use of a unique and understudied sample –
detoxification treatment-seekers – which may have different characteristics than other samples.
Further, we included comorbid psychiatric disorders as key variables (indicators) in the LCA
rather than external variables examined post-LCA. In other words, we used probable MDD,
PTSD, and multiple SUD diagnoses as variables to define the classes, rather than defining
classes by substance and examining how MDD and PTSD varied among the classes post-hoc.
The classes identified have implications for screening and referral processes used in the
detoxification treatment setting. The MDD-Poly SUD class was characterized by high rates of
both opioid and alcohol use disorders in comparison to the other classes. Given that alcohol use
is present in nearly half of all fatal opioid overdoses (Warner-Smith, Darke, Lynskey, & Hall,
2001), this group is at significant risk for overdose, underscoring the importance of addressing
opioid use in the context of alcohol use for members of this class. Referrals to outpatient
psychotherapy or in-house psychosocial interventions – in conjunction with pharmacotherapy
utilizing naltrexone or naloxone – may be important for consolidating treatment gains made in
detoxification and may be especially important to minimize the risk of fatal overdose.
The variability of alcohol use disorders between classes is consistent with research
suggesting that alcohol use disorders are highly heterogeneous. Following, future treatment
research should focus on mechanisms specific to the cycles of alcohol addiction, such as greater
emphasis on reducing negative affect during withdrawal early in treatment and tolerating craving
later in treatment (Litten, et al., 2015). In addition, both the PTSD-MDD-Poly SUD and the
MDD-Poly SUD classes were characterized by concurrent opioid and cannabis use disorders.
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This finding is consistent with research implicating the endocannabinoid system in opioid
dependence and the potential effectiveness of pharmacotherapies targeting the endocannabinoid
system in alleviating opioid withdrawal during detoxification (Bisaga et al., 2015).
Examination of key clinical characteristics indicated that people in the PTSD-MDD-Poly
SUD class had more severe addiction problems as well as more severe PTSD/MDD symptom
severity than people in other classes. In particular, it is notable that this class had more severe
substance use problems even with respect to substances that were used less frequently (i.e.,
substances not characteristic of that LCA class). Not only were the symptoms of each individual
disorder more severe, this class also had a more severe trauma history than other classes. Thus,
trauma history characteristics of this class may be contributing factors to the elevated rates of
probable PTSD and MDD observed. Notably, this class had more women, and women are more
likely to experience interpersonal trauma (Black et al., 2011). Referrals to individual outpatient
psychotherapy may be particularly important for long-term recovery for this group, especially
women, given the reciprocal relationship between PTSD and SUD symptoms (Read et al., 2004).
Women in this class who experience trauma symptoms arising from interpersonal violence may
be less comfortable with mixed gender settings.
Interventions that can target specific constructs or processes that are shared across
disorders or diagnostic profiles are recommended. Many who seek detoxification continue to
struggle one year later (Franken & Hendriks, 1999) suggesting that increasing the services
offered at detoxification facilities or expanding referral networks based on baseline assessments
of comorbidities may be fruitful for improving long-term recovery. For example, motivational
interviews rather than advice regarding ongoing treatment have been associated with less
substance use at follow-up (Vederhus, Timko, Kristensen, Hjemdahl, & Clausen, 2014),
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illustrating the importance of providing brief interventions as part of the treatment planning
process even when services are not provided at the detoxification facility. Motivational
interviewing can be easily adapted for specific problems and is one way in which integrated
treatment programs can be designed to match diagnostic profiles. For example, people in the
PTSD-MDD-Poly SUD class may benefit more from motivational interviewing that discusses
anxiety and avoidance symptoms whereas those in the alcohol-tobacco class may benefit from
substance use focused motivational interviewing.
Our results also point to transdiagnostic approaches in outpatient care to improve
symptoms and reduce distress in a time- and cost-effective manner. Transdiagnostic
interventions can be delivered as modules in group formats with each group targeting different
processes. The groups could be offered simultaneously, and treatment-seekers could be referred
to groups based on their diagnostic profiles. For example, interventions for anxiety sensitivity
and nicotine replacement therapy could be offered simultaneously with referrals made based on
comorbidity profile. Anxiety sensitivity has been shown to be amenable to a number of treatment
approaches in a range of anxiety disorders (Lejuez et al., 2008). Anxiety sensitivity may be a
useful target for the PTSD-MDD-Poly SUD class identified here. Another potential target is
distress tolerance, which is related to anxiety sensitivity and strongly linked to substance use
disorders (Buckner, Keough, & Schmidt, 2007). Newly developed interventions for distress
tolerance have been well received by depressed substance use patients (Bornovalova, Gratz,
Daughters, Hunt, & Lejuez, 2012). The brief interventions that have been developed for both
anxiety sensitivity and distress tolerance have the potential to be easily combined with other
treatment components to create integrated, multifaceted interventions that can be provided in
short-term focused treatment settings or as transition pieces for longer term care. Distress
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tolerance would be relevant for all the classes identified in this study and may be especially
relevant for those in the PTSD-MDD-Poly SUD class given the elevated rates of probable PTSD
and MDD that characterize members of this subgroup. Distress tolerance may be an especially
useful skill to learn early in detoxification settings where treatment seekers may be experiencing
acute, painful withdrawal symptoms.
It should be noted that treatment-matching practices such as those proposed above have
shown mixed benefits when applied in formal addiction treatment settings (e.g., Project MATCH
Research Group, 1997). However, much past research specifically excluded detoxification
seekers. It should be noted that the characteristics identified in Project MATCH that were
associated with differential treatment outcome (severity of psychopathology, anger, desire for
meaning making) are those which are elevated in PTSD-SUD comorbidity samples. Those
studies showing success with integrative treatments (e.g., McLellan et al., 1997; Thornton,
Gottheil, Weinstein, & Kerachsky, 1998) have demonstrated that integrative services are most
appropriate for those patients presenting with the most complex clinical problems. This is
consistent with our findings suggesting that those individuals in the PTSD-MDD-Poly SUD class
may require additional resources compared to patients in the classes with less severe clinical
presentations. For example, women are more likely to be in this class and more likely to
experience treatment barriers related to childcare and parenting (Copeland, 1997). Thus referrals
which can accommodate childcare needs are necessary; motivational interviewing and structured
problem solving around these needs are also recommended. Even so, additional research
replicating our findings should be performed to substantiate support for the existence of the
classes observed. We also recommend future research examine differences in motivation and
post-discharge treatment trajectories.
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Self-report measures of PTSD and MDD were used to ascertain probable diagnoses; thus,
the findings may be limited by the methodological constraints associated with self-report.
Further, the assessment of depression is especially difficult in people who use substances as
these symptoms could be caused by substance use and/or detoxification from substances.
However, the PCL is highly correlated with clinician interview measures of PTSD (r = .93:
Blanchard et al., 1996), and people who use substances may be more truthful in disclosing
symptoms in self-report than interview formats (Islam et al., 2012). Second, the present study
consists of individuals who were seeking medically assisted detoxification; these participants
may have more severe symptoms or less social support than other treatment-seeking samples,
and results may not generalize to all non-addiction samples. That said, detoxification treatment is
an under-researched treatment setting in comparison to typical outpatient treatment, despite the
unique features and public health importance of this setting. Finally, future research should
examine a broader number of potential diagnostic comorbidities, particularly diagnoses
associated with more challenging clinical presentations such as attention deficit-hyperactivity,
bipolar, or borderline personality disorders.
4.1 Conclusions
In conclusion, the current study found evidence for differential patterns of PTSD-SUDMDD comorbidity in detoxification treatment seekers that indicate the need for tailored referral
and treatment programs that can flexibly address specific substances or constructs. Integrative
treatment approaches that include different components specialized to target different constructs
that are associated with different diagnostic profiles (anxiety sensitivity, distress tolerance,
opioid withdrawal, etc.,) are recommended as are referral networks which can identify settings
and providers that offer these services.

RUNNING HEAD: Patterns of Comorbidity in Detoxification Treatment Seekers

20
References
Ali, R., Awwad, E., Babor, T., Bradley, F., Butau, T., Farrell, M., … Vendetti, J. (2002). The
Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development,
reliability and feasibility. Addiction, 97(9), 1183–1194. http://doi.org/10.1046/j.13600443.2002.00185.x

Berenz, E. C., & Coffey, S. F. (2012). Treatment of co-occurring posttraumatic stress disorder
and substance use disorders. Current Psychiatry Reports. http://doi.org/10.1007/s11920012-0300-0

Bisaga, A., Sullivan, M. A., Glass, A., Mishlen, K., Pavlicova, M., Haney, M., … Nunes, E. V.
(2015). The effects of dronabinol during detoxification and the initiation of treatment
with extended release naltrexone. Drug and Alcohol Dependence, 154, 38–45.
http://doi.org/10.1016/j.drugalcdep.2015.05.013

Black, M. C., Basile, K. C., Breiding, M. J., Smith, S., Walters, M. L., Merrick, M., … Stevens,
M. (2011). The National Intimate Partner and Sexual Violence Survey (NISVS): 2010
Summary Report. Atlanta, GA, USA.
Blanchard, E. B., Jones-Alexander, J., Buckley, T. C., & Forneris, C. A. (1996). Psychometric
properties of the PTSD Checklist (PCL). Behaviour Research and Therapy, 34(8), 669–
673. http://doi.org/10.1016/0005-7967(96)00033-2
Blanchard, K. A., Morgenstern, J., Morgan, T. J., Lobouvie, E. W., & Bux, D. A. (2003).
Assessing Consequences of Substance Use: Psychometric Properties of the Inventory of
Drug Use Consequences. Psychology of Addictive Behaviors, 17(4), 328–331.
http://doi.org/10.1037/0893-164X.17.4.328

RUNNING HEAD: Patterns of Comorbidity in Detoxification Treatment Seekers

21
Bornovalova, M. A., Gratz, K. L., Daughters, S. B., Hunt, E. D., & Lejuez, C. W. (2012). Initial
RCT of a distress tolerance treatment for individuals with substance use disorders. Drug
and Alcohol Dependence, 122(1–2), 70–76.
http://doi.org/10.1016/j.drugalcdep.2011.09.012
Branson, C. E., Clemmey, P., Harrell, P., Subramaniam, G., & Fishman, M. (2012).
Polysubstance use and heroin relapse among adolescents following residential treatment.
Journal of Child & Adolescent Substance Abuse, 21(3), 204–221.
http://doi.org/10.1080/1067828X.2012.689803
Buckner, J. D., Keough, M. E., & Schmidt, N. B. (2007). Problematic alcohol and cannabis use
among young adults: The roles of depression and discomfort and distress tolerance.
Addictive Behaviors, 32(9), 1957–1963. http://doi.org/10.1016/j.addbeh.2006.12.019
Coffey, S. F., Schumacher, J. A., Brimo, M. L., & Brady, K. T. (2005). Exposure Therapy for
Substance Abusers with PTSD. Behavior Modification, 29(1), 10–38.
http://doi.org/10.1177/0145445504270855

Cohen, E., Feinn, R., Arias, A., & Kranzler, H. R. (2007). Alcohol treatment utilization: Findings
from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and
Alcohol Dependence, 86(2–3), 214–221. http://doi.org/10.1016/j.drugalcdep.2006.06.008

Copeland, J. (1997). A qualitative study of barriers to formal treatment among women who selfmanaged change in addictive behaviours. Journal of substance abuse treatment, 14(2),
183-190.
Connor, J. P., Gullo, M. J., Chan, G., Young, R. M., Hall, W. D., & Feeney, G. F. X. (2013).
Polysubstance use in cannabis users referred for treatment: Drug use profiles, psychiatric

RUNNING HEAD: Patterns of Comorbidity in Detoxification Treatment Seekers

22
comorbidity and cannabis-related beliefs. Frontiers in Psychiatry, 4.
http://doi.org/10.3389/fpsyt.2013.00079
Conway, K. P., Vullo, G. C., Nichter, B., Wang, J., Compton, W. M., Iannotti, R. J., & SimonsMorton, B. (2013). Prevalence and patterns of polysubstance use in a nationally
representative sample of 10th graders in the United States. Journal of Adolescent Health,
52(6), 716–723. http://doi.org/10.1016/j.jadohealth.2012.12.006
Darke, S., Marel, C., Mills, K. L., Ross, J., Slade, T., Burns, L., & Teesson, M. (2014). Patterns
and correlates of non-fatal heroin overdose at 11-year follow-up: Findings from the
Australian Treatment Outcome Study. Drug and Alcohol Dependence, 144, 148–152.
http://doi.org/10.1016/j.drugalcdep.2014.09.001
Eaton, W. W., Smith, C., Ybarra, M., Muntaner, C., & Tien, A. (2004). Center for Epidemiologic
Studies Depression Scale: Review and Revision (CESD and CESD-R). In The use of
psychological testing for treatment planning and outcomes assessment: Volume 3:
Instruments for adults (3rd ed) (pp. 363–377). Mahwah, NJ, US: Lawrence Erlbaum
Associates Publishers.
Erfan, S., Hashim, A. H., Shaheen, M., & Sabry, N. (2010). Effect of comorbid depression on
substance use disorders. Substance Abuse, 31(3), 162–169.
http://doi.org/10.1080/08897077.2010.495311
Foa, E. B., Cashman, L., Jaycox, L., & Perry, K. (1997). The validation of a self-report measure
of posttraumatic stress disorder: The Posttraumatic Diagnostic Scale. Psychological
Assessment, 9(4), 445–451. http://doi.org/10.1037/1040-3590.9.4.445
Franken, I. H., & Hendriks, V. M. (1999). Predicting outcome of inpatient detoxification of
substance abusers. Psychiatric Services (Washington, D.C.), 50(6), 813–7. Retrieved

RUNNING HEAD: Patterns of Comorbidity in Detoxification Treatment Seekers

23
from http://www.ncbi.nlm.nih.gov/pubmed/10375152
Freyer-Adam, J., Gaertner, B., Rumpf, H. J., John, U., & Hapke, U. (2010). Alcohol dependent
inpatients who receive general hospital care vs. detoxification in psychiatric care and
alcohol problem 1 year later. Addictive Behaviors, 35(8), 756–763.
Galatzer‐Levy, I. R., Nickerson, A., Litz, B. T., & Marmar, C. R. (2013). Patterns of lifetime
PTSD comorbidity: A latent class analysis. Depression and Anxiety, 30(5), 489–496.
http://doi.org/10.1002/da.22048
Hien, D. A., Wells, E. A., Jiang, H., Suarez-Morales, L., Campbell, A. N. C., Cohen, L. R., …
Nunes, E. V. (2009). Multisite randomized trial of behavioral interventions for women
with co-occurring PTSD and substance use disorders. Journal of Consulting and Clinical
Psychology, 77(4), 607–619. http://doi.org/10.1037/a0016227
Hudziak, J., Helzer, J., Wetzel, M., Kessel, K., McGee, B., Janca, A., & Przybeck, T. (1993).
The use of the DSM-III-R Checklist for initial diagnostic assessments. Comprehensive
Psychiatry, 34(6), 375–383. http://doi.org/10.1016/0010-440X(93)90061-8
Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015). Prevalence of comorbid
substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A
systematic review and meta-analysis. Drug and Alcohol Dependence.
http://doi.org/10.1016/j.drugalcdep.2015.05.031
Lejuez, C. W., Zvolensky, M. J., Daughters, S. B., Bornovalova, M. A., Paulson, A., Tull, M. T.,
… Otto, M. W. (2008). Anxiety sensitivity: A unique predictor of dropout among innercity heroin and crack/cocaine users in residential substance use treatment. Behaviour
Research and Therapy, 46(7), 811–818. http://doi.org/10.1016/j.brat.2008.03.010

RUNNING HEAD: Patterns of Comorbidity in Detoxification Treatment Seekers

24
Litten, R. Z., Ryan, M. L., Falk, D. E., Reilly, M., Fertig, J. B., & Koob, G. F. (2015).
Heterogeneity of alcohol use disorder: Understanding mechanisms to advance personalized
treatment. Alcoholism: Clinical and Experimental Research, 39(4), 579–584.
http://doi.org/10.1111/acer.12669

Mattson, M.E., Allen, J.P., Longabaugh, R., Nickless, C., Connors, G.J., & Kadden, R.M.
(1994). A chronological review of empirical studies matching alcoholic clients to
treatment. Journal of Studies on Alcohol Supplement 12, 16-29.
McLellan, A.T., Grissom, G.R., Zanis, D., Randall, M., Brill, P., & O’Brien, C.P. (1997).
Problem-service ‘matching’ in addiction treatment. Archives of General Psychiatry, 54,
730-735.
Moss, H. B., Goldstein, R. B., Chen, C. M., & Yi, H.-Y. (2015). Patterns of use of other drugs
among those with alcohol dependence: Associations with drinking behavior and
psychopathology. Addictive Behaviors, 50, 192–198.
http://doi.org/10.1016/j.addbeh.2015.06.041

Najavits, L. M., Weiss, R. D., & Shaw, S. R. (1997). The Link Between Substance Abuse and
Posttraumatic Stress Disorder in Women. The American Journal on Addictions, 6(4), 273–
283. http://doi.org/10.1111/j.1521-0391.1997.tb00408.x

National Center for PTSD. (2014). Using the PTSD Checklist for DSM-IV. Retrieved from
http://www.ptsd.vs.gov/professional/pages/assessments/assessment-pdf/PCL-handout.pdf
Nixon, R. D. V, Resick, P. A., & Nishith, P. (2004). An exploration of comorbid depression
among female victims of intimate partner violence with posttraumatic stress disorder.
Journal of Affective Disorders, 82(2), 315–320. http://doi.org/10.1016/j.jad.2004.01.008

RUNNING HEAD: Patterns of Comorbidity in Detoxification Treatment Seekers

25
Project MATCH Research Group. (1997). Matching alcoholism treatments to clients
heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on
Alcohol, 58, 7-29.

Quello, S. B., Brady, K. T., & Sonne, S. C. (2005). Mood disorders and substance use disorder: a
complex comorbidity. Science & Practice Perspectives / a Publication of the National
Institute on Drug Abuse, National Institutes of Health, 3(1), 13–21.
http://doi.org/10.1151/spp053113

Read, J. P., Brown, P. J., & Kahler, C. W. (2004). Substance use and posttraumatic stress
disorders: Symptom interplay and effects on outcome. Addictive Behaviors, 29(8), 1665–
1672. http://doi.org/10.1016/j.addbeh.2004.02.061
Substance Abuse and Mental Health Services Administration. (2006). Detoxification and
Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series 45. Treatment
Improvement Protocol (TIP) Series 45. Rockville, MD.
Tait, R. J., Hulse, G. K., Robertson, S. I., & Sprivulis, P. C. (2005). Emergency departmentbased intervention with adolescent substance users: 12-month outcomes. Drug and
Alcohol Dependence, 79(3), 359–363. http://doi.org/10.1016/j.drugalcdep.2005.03.015
Thornton, C.C., Gottheil, E., Weinstein, S.P., & Kerachsky, R.S. (1998). Patient-treatment
matching in substance abuse drug addiction severity. Journal of Substance Abuse
Treatment, 15, 505-511.
Tómasson, K., & Vaglum, P. (1998). The role of psychiatric comorbidity in the prediction of
readmission for detoxification. Comprehensive Psychiatry, 39(3), 129–136.
Tomczyk, S., Isensee, B., & Hanewinkel, R. (2015). Latent classes of polysubstance use among

RUNNING HEAD: Patterns of Comorbidity in Detoxification Treatment Seekers

26
adolescents—a systematic review. Drug and Alcohol Dependence, 160, 12–29.
http://doi.org/10.1016/j.drugalcdep.2015.11.035
Ullman, S. E., & Long, S. M. (2008). Factor structure of PTSD in a community sample of sexual
assault survivors. Journal of Trauma & Dissociation, 9(4), 507–524.
Vederhus, J. K., Timko, C., Kristensen, Ø., Hjemdahl, B., & Clausen, T. (2014). Motivational
intervention to enhance post-detoxification 12-Step group affiliation: A randomized
controlled trial. Addiction, 109(5), 766–773.
Warner-Smith, M., Darke, S., Lynskey, M., & Hall, W. (2001). Heroin overdose: Causes and
consequences. Addiction, 96(8), 1113–1125. http://doi.org/10.1080/09652140120060716
Wolfe, J., Kimerling, R., Brown, P. J., Chrestman, K. R., & Levin, K. (1996). Psychometric
review of the life stressor checklist-revised. In B. Stamm (Ed.), Measurement of stress,
trauma, and adaptation (pp. 198–201). Lutherville, MD: Sidran Press.

RUNNING HEAD: Patterns of Comorbidity in Detoxification Treatment Seekers

27
Tables
Table 1
Class proportions (%) of indicator variables for the 4 class model, N = 375.
Indicator

PTSD-MDD-

MDD-Poly

Alcohol-

Opioid-

Overall

Poly SUD (1)

SUD (2)

Tobacco (3)

Tobacco (4)

Prevalence

n = 89, 23.7%

n = 94, 25.1%

n = 85, 22.7% n = 107 , 28.5%

N = 375

PTSD

84.8

51.0

38.7

20.3

47.2

MDD

100.0

79.0

41.8

40.2

64.0

Opioid

100.0

91.2

0.0

99.0

76.0

Alcohol

24.0

100.0

100.0

20.5

56.0

Sedative

35.5

42.2

2.3

17.2

24.0

Amphetamine

12.6

24.3

0.0

14.7

13.1

Cocaine

34.8

52.2

13.3

10.0

26.1

Tobacco

88.1

77.8

74.4

83.9

81.6

Cannabis

64.7

76.3

27.8

43.4

52.5

Note. Table numbers indicate the percentage of participants in the class classified by the diagnosis
(indicator variable). Bolded values indicate the diagnoses that were characteristic (60% or greater)
for that class.
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Table 2
Fit indices for latent class models
Latent Class Models

AIC

BIC

SSA-BIC

LMR LRT

BLRT

Entropy

2-class

3771.8

3846.4

3786.2

211.0***

214.5***

0.97

3-class

3724.7

3838.6

3746.6

66.0

67.1***

0.73

4-class

3714.0

3867.1

3743.4

30.2

30.7***

0.74

5-class

3718.1

3910.5

3755.1

15.6

15.9

0.78

Note. AIC = Akaike information criterion, BIC = Bayesian information criterion, SSA-BIC =
sample size adjusted BIC, LMR LRT =, Lo-Mendell-Rubin likelihood ratio test, BLRT =
Bootstrap likelihood ratio test
** p <.01, ***p <.001
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Table 3
Means, standard deviations, prevalences, and statistical differences between the PTSD-MDD-Poly SUD class and other classes
Variables

PTSD-MDD-

MDD-Poly

Alcohol-

Opioid-

Statistical Test (omnibus)

Poly SUD (1)

SUD (2)

Tobacco (3)

Tobacco (4)

23.7%

25.1%

22.7%

28.5%

Opioid problems (M,SD)

31.8(5.8)abc

27.7(10.0)a

4.0(7.8)b

28.9(7.4)c

F(3, 370) = 228.5, p < .001

Alcohol problems (M,SD)

7.9(10.2)ab

19.6(13.4)a

32.4(7.1)b

6.0(8.0)

F(3, 371) = 137.0, p < .001

Cannabis problems (M,SD)

14.8(12.9)ab

13.2(11.2)

5.7(9.7)a

8.3(10.5)b

F(3, 370) = 12.9, p < .001

Sedative problems (M,SD)

11.5(12.5)ab

11.5(11.2)

4.1(8.0)a

6.3(8.6)b

F(3, 370) = 12.1, p < .001

Cocaine problems (M,SD)

13.1(12.8)ab

16.3(13.6)

4.8(9.8)a

5.3(8.4)b

F(3, 370) = 24.1, p < .001

Amphetamine problems (M,SD)

6.2(9.5)a

9.6(11.3)

1.7(5.2)a

5.7(9.3)

F(3, 369) = 11.0, p < .001

Tobacco problems (M,SD)

24.5(8.2)

21.7(9.0)

22.3(10.8)

21.7(8.22)

F(3, 371) = 1.93, p = 0.12

Negative consequences of use (M,SD)

40.7(6.2)abc

36.8(9.2)a

32.8(10.9)b

33.0(10.7)c

F(3, 371) = 14.1, p < .001

Physical assault pre 16 (% within class)

23.6%a

27.7%

22.4%

11.2%a

χ2(3) = 9.2, p =.03

Physical assault after 16 (% within class)

36.0%a

25.5%

24.7%

27.1%a

χ2(3) = 9.4, p = .02
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Sexual Assault pre 16 (% within class)

22.5%ab

17.0%

9.4%a

4.7%b

χ2(3) = 15.9, p = .001

Sexual Assault after 16 (% within class)

20.2%ab

17.0%

5.9%a

3.7%b

χ2(3) = 18.5, p <.001

PTSD severity (M,SD)

60.3(13.5)abc

51.0(19.0)a

43.0(19.8)b

36.6(14.6)c

F(3, 371) = 35.2, p < .001

MDD severity (M,SD)

61.6(11.2)ab

58.2(15.1)

42.0(20.5)a

42.6(18.1)b

F(3, 371) = 35.5, p < .001

Gender (% women within class)

59.6%abc

35.1%a

27.1%b

37.4%c

χ2(3) = 21.39, p <.001

Note. Statistics with the same super script differ at the p < 0.05 significance level.

